This is a preview of subscription content, log in via an institution to check access.
Reference
Alsumali A, et al. Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event. . Advances in Therapy : 16 Apr 2021
Rights and permissions
About this article
Cite this article
Vericiguat has minimal budget impact as add-on therapy for heart failure. PharmacoEcon Outcomes News 877, 28 (2021). https://doi.org/10.1007/s40274-021-7677-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7677-0